Samsung Biologics has opened its first U.S. CDO R&D Center in San Francisco, CA, bringing its contract development services closer to global clients. Aligned with the company’s mission to offer a seamless one-stop service, the new facility will utilize the same CDO research and development capabilities present at its headquarters in Incheon, South Korea. Samsung Biologics says its CDO business delivers cell line development to DS manufacturing in six months, and to DP manufacturing in seven ...